Listed

Kiora Pharmaceuticals Inc

KPRXNasdaqCIK 1372514HealthcareFiscal year ends Dec 31

Reports and events: 268 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Kiora Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2017-09-1107:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-047364
2017-08-0416:13 ET10-QQuarterly reportPeriod 2017-06-300001144204-17-040582
2017-06-2216:15 ET8-K5.07 Shareholder vote results0001144204-17-033616
2017-06-1616:48 ETSC 13D/AOwnership report, active investor, amended0001144204-17-032894
2017-06-1606:01 ETSC 13D/AOwnership report, active investor, amended0001144204-17-032811
2017-06-1416:40 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-032545
2017-06-0907:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-031812
2017-06-0516:19 ETS-1/ARegistration statement, amended0001144204-17-031012
2017-05-0516:31 ETS-1/ARegistration statement, amended0001144204-17-024866
2017-05-0516:17 ET10-QQuarterly reportPeriod 2017-03-310001144204-17-024841
2017-05-0407:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-024367
2017-04-2816:17 ETDEF 14AProxy statementPeriod 2017-06-210001144204-17-023225
2017-04-2116:30 ETS-1Registration statement0001144204-17-021542
2017-04-1316:30 ET8-K3.01 Delisting notice0001144204-17-020354
2017-03-1007:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-013840
2017-02-2316:02 ET10-KAnnual reportPeriod 2016-12-310001144204-17-010635
2017-02-2107:40 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001144204-17-009977
2017-02-0616:15 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-006202
2017-01-3008:40 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-004472
2017-01-0907:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-001211
2016-12-2216:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-16-140966
2016-12-1916:21 ET8-K5.02 Departure or appointment of officers or directors0001144204-16-140253
2016-11-1716:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-135172
2016-11-0117:12 ET10-QQuarterly reportPeriod 2016-09-300001144204-16-130888
2016-09-1208:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-16-123499
2016-08-1016:46 ET10-QQuarterly reportPeriod 2016-06-300001144204-16-118057
2016-08-0108:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-115473
2016-06-3014:05 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-110759
2016-06-2708:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-109892
2016-06-2216:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001144204-16-109307
2016-06-0108:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-106102
2016-05-2518:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-104583
2016-05-2317:25 ET8-K/A9.01 Financial statements and exhibits0001144204-16-104275
2016-05-1317:19 ET10-QQuarterly reportPeriod 2016-03-310001144204-16-101911
2016-04-2916:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-097797
2016-04-2816:07 ETDEF 14AProxy statementPeriod 2016-06-210001144204-16-097076
2016-03-3016:08 ET10-KAnnual reportPeriod 2015-12-310001144204-16-091485
2016-03-0717:23 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-086425
2016-01-2616:21 ET8-K5.02 Departure or appointment of officers or directors0001144204-16-077008
2016-01-1906:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-16-075910
2015-11-1206:09 ET10-QQuarterly reportPeriod 2015-09-300001144204-15-064326
2015-09-0812:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-15-053959
2015-08-1413:58 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-15-049615
2015-08-1217:16 ET10-QQuarterly reportPeriod 2015-06-300001144204-15-048608
2015-08-0516:15 ET8-K1.01 Entry into a material agreement; 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-046516
2015-07-3014:42 ETS-1/ARegistration statement, amended0001144204-15-045116
2015-07-3017:31 ETS-1/ARegistration statement, amended0001144204-15-044920
2015-07-2816:11 ETS-1/ARegistration statement, amended0001144204-15-044597
2015-07-1517:20 ETS-1/ARegistration statement, amended0001144204-15-042717
2015-07-1016:50 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001144204-15-042062

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.